Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Did the FDA Move the BTD Goal Posts?

<< Previous

Bullboard Posts

Next >>

Comment by Kingpin68on Dec 05, 2023 10:17am

246 Views

Post# 35768873

RE:RE:Did the FDA Move the BTD Goal Posts?

Honestly, I can imagine dealing with the FDA is not easy, so it's possible TLT hasn't done anything 'wrong'. No doubt that the FDA can change direction or ask for this or that on a whim. So TLT is stuck with this dance. But there is no denying that ruvidar works better and safer than anything else, those numbers can't be denied.

<< Previous

Bullboard Posts

Next >>

Cannara reports record growth and profitability in Q4 2023